Cargando…

From HIV to COVID-19, Molecular mechanisms of pathogens’ trade-off and persistence in the community, potential targets for new drug development

BACKGROUND: On the staggering emergence of the Omicron variant, numerous questions arose about the evolution of virulence and transmissibility in microbes. MAIN BODY OF THE ABSTRACT: The trade-off hypothesis has long speculated the exchange of virulence for the sake of superior transmissibility in a...

Descripción completa

Detalles Bibliográficos
Autores principales: AbdelMassih, Antoine, Sedky, Abrar, Shalaby, Ahmed, Shalaby, AlAmira-Fawzia, Yasser, Alia, Mohyeldin, Aya, Amin, Basma, Saleheen, Basma, Osman, Dina, Samuel, Elaria, Abdelfatah, Emmy, Albustami, Eveen, ElGhamry, Farida, Khaled, Habiba, Amr, Hana, Gaber, Hanya, Makhlouf, Ismail, Abdeldayem, Janna, El-Beialy, Jana Waleed, Milad, Karim, El Sharkawi, Laila, Abosenna, Lina, Safi, Madonna G., AbdelKareem, Mariam, Gaber, Marwa, Elkady, Mirna, Ihab, Mohamed, AbdelRaouf, Nora, Khaled, Rawan, Shalata, Reem, Mahgoub, Rudayna, Jamal, Sarah, El Hawary, Seif El-Din, ElRashidy, Shady, El Shorbagy, Sherouk, Gerges, Tony, Kassem, Yara, Magdy, Yasmeen, Omar, Yasmin, Shokry, Yasmine, Kamel, Aya, Hozaien, Rafeef, El-Husseiny, Nadine, El Shershaby, Meryam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258762/
https://www.ncbi.nlm.nih.gov/pubmed/35818410
http://dx.doi.org/10.1186/s42269-022-00879-w
_version_ 1784741619406209024
author AbdelMassih, Antoine
Sedky, Abrar
Shalaby, Ahmed
Shalaby, AlAmira-Fawzia
Yasser, Alia
Mohyeldin, Aya
Amin, Basma
Saleheen, Basma
Osman, Dina
Samuel, Elaria
Abdelfatah, Emmy
Albustami, Eveen
ElGhamry, Farida
Khaled, Habiba
Amr, Hana
Gaber, Hanya
Makhlouf, Ismail
Abdeldayem, Janna
El-Beialy, Jana Waleed
Milad, Karim
El Sharkawi, Laila
Abosenna, Lina
Safi, Madonna G.
AbdelKareem, Mariam
Gaber, Marwa
Elkady, Mirna
Ihab, Mohamed
AbdelRaouf, Nora
Khaled, Rawan
Shalata, Reem
Mahgoub, Rudayna
Jamal, Sarah
El Hawary, Seif El-Din
ElRashidy, Shady
El Shorbagy, Sherouk
Gerges, Tony
Kassem, Yara
Magdy, Yasmeen
Omar, Yasmin
Shokry, Yasmine
Kamel, Aya
Hozaien, Rafeef
El-Husseiny, Nadine
El Shershaby, Meryam
author_facet AbdelMassih, Antoine
Sedky, Abrar
Shalaby, Ahmed
Shalaby, AlAmira-Fawzia
Yasser, Alia
Mohyeldin, Aya
Amin, Basma
Saleheen, Basma
Osman, Dina
Samuel, Elaria
Abdelfatah, Emmy
Albustami, Eveen
ElGhamry, Farida
Khaled, Habiba
Amr, Hana
Gaber, Hanya
Makhlouf, Ismail
Abdeldayem, Janna
El-Beialy, Jana Waleed
Milad, Karim
El Sharkawi, Laila
Abosenna, Lina
Safi, Madonna G.
AbdelKareem, Mariam
Gaber, Marwa
Elkady, Mirna
Ihab, Mohamed
AbdelRaouf, Nora
Khaled, Rawan
Shalata, Reem
Mahgoub, Rudayna
Jamal, Sarah
El Hawary, Seif El-Din
ElRashidy, Shady
El Shorbagy, Sherouk
Gerges, Tony
Kassem, Yara
Magdy, Yasmeen
Omar, Yasmin
Shokry, Yasmine
Kamel, Aya
Hozaien, Rafeef
El-Husseiny, Nadine
El Shershaby, Meryam
author_sort AbdelMassih, Antoine
collection PubMed
description BACKGROUND: On the staggering emergence of the Omicron variant, numerous questions arose about the evolution of virulence and transmissibility in microbes. MAIN BODY OF THE ABSTRACT: The trade-off hypothesis has long speculated the exchange of virulence for the sake of superior transmissibility in a wide array of pathogens. While this certainly applies to the case of the Omicron variant, along with influenza virus, various reports have been allocated for an array of pathogens such as human immunodeficiency virus (HIV), malaria, hepatitis B virus (HBV) and tuberculosis (TB). The latter abide to another form of trade-off, the invasion–persistence trade-off. In this study, we aim to explore the molecular mechanisms and mutations of different obligate intracellular pathogens that attenuated their more morbid characters, virulence in acute infections and invasion in chronic infections. SHORT CONCLUSION: Recognizing the mutations that attenuate the most morbid characters of pathogens such as virulence or persistence can help in tailoring new therapies for such pathogens. Targeting macrophage tropism of HIV by carbohydrate-binding agents, or targeting the TMPRSS2 receptors to prevent pulmonary infiltrates of COVID-19 is an example of how important is to recognize such genetic mechanisms.
format Online
Article
Text
id pubmed-9258762
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-92587622022-07-07 From HIV to COVID-19, Molecular mechanisms of pathogens’ trade-off and persistence in the community, potential targets for new drug development AbdelMassih, Antoine Sedky, Abrar Shalaby, Ahmed Shalaby, AlAmira-Fawzia Yasser, Alia Mohyeldin, Aya Amin, Basma Saleheen, Basma Osman, Dina Samuel, Elaria Abdelfatah, Emmy Albustami, Eveen ElGhamry, Farida Khaled, Habiba Amr, Hana Gaber, Hanya Makhlouf, Ismail Abdeldayem, Janna El-Beialy, Jana Waleed Milad, Karim El Sharkawi, Laila Abosenna, Lina Safi, Madonna G. AbdelKareem, Mariam Gaber, Marwa Elkady, Mirna Ihab, Mohamed AbdelRaouf, Nora Khaled, Rawan Shalata, Reem Mahgoub, Rudayna Jamal, Sarah El Hawary, Seif El-Din ElRashidy, Shady El Shorbagy, Sherouk Gerges, Tony Kassem, Yara Magdy, Yasmeen Omar, Yasmin Shokry, Yasmine Kamel, Aya Hozaien, Rafeef El-Husseiny, Nadine El Shershaby, Meryam Bull Natl Res Cent Review BACKGROUND: On the staggering emergence of the Omicron variant, numerous questions arose about the evolution of virulence and transmissibility in microbes. MAIN BODY OF THE ABSTRACT: The trade-off hypothesis has long speculated the exchange of virulence for the sake of superior transmissibility in a wide array of pathogens. While this certainly applies to the case of the Omicron variant, along with influenza virus, various reports have been allocated for an array of pathogens such as human immunodeficiency virus (HIV), malaria, hepatitis B virus (HBV) and tuberculosis (TB). The latter abide to another form of trade-off, the invasion–persistence trade-off. In this study, we aim to explore the molecular mechanisms and mutations of different obligate intracellular pathogens that attenuated their more morbid characters, virulence in acute infections and invasion in chronic infections. SHORT CONCLUSION: Recognizing the mutations that attenuate the most morbid characters of pathogens such as virulence or persistence can help in tailoring new therapies for such pathogens. Targeting macrophage tropism of HIV by carbohydrate-binding agents, or targeting the TMPRSS2 receptors to prevent pulmonary infiltrates of COVID-19 is an example of how important is to recognize such genetic mechanisms. Springer Berlin Heidelberg 2022-07-06 2022 /pmc/articles/PMC9258762/ /pubmed/35818410 http://dx.doi.org/10.1186/s42269-022-00879-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review
AbdelMassih, Antoine
Sedky, Abrar
Shalaby, Ahmed
Shalaby, AlAmira-Fawzia
Yasser, Alia
Mohyeldin, Aya
Amin, Basma
Saleheen, Basma
Osman, Dina
Samuel, Elaria
Abdelfatah, Emmy
Albustami, Eveen
ElGhamry, Farida
Khaled, Habiba
Amr, Hana
Gaber, Hanya
Makhlouf, Ismail
Abdeldayem, Janna
El-Beialy, Jana Waleed
Milad, Karim
El Sharkawi, Laila
Abosenna, Lina
Safi, Madonna G.
AbdelKareem, Mariam
Gaber, Marwa
Elkady, Mirna
Ihab, Mohamed
AbdelRaouf, Nora
Khaled, Rawan
Shalata, Reem
Mahgoub, Rudayna
Jamal, Sarah
El Hawary, Seif El-Din
ElRashidy, Shady
El Shorbagy, Sherouk
Gerges, Tony
Kassem, Yara
Magdy, Yasmeen
Omar, Yasmin
Shokry, Yasmine
Kamel, Aya
Hozaien, Rafeef
El-Husseiny, Nadine
El Shershaby, Meryam
From HIV to COVID-19, Molecular mechanisms of pathogens’ trade-off and persistence in the community, potential targets for new drug development
title From HIV to COVID-19, Molecular mechanisms of pathogens’ trade-off and persistence in the community, potential targets for new drug development
title_full From HIV to COVID-19, Molecular mechanisms of pathogens’ trade-off and persistence in the community, potential targets for new drug development
title_fullStr From HIV to COVID-19, Molecular mechanisms of pathogens’ trade-off and persistence in the community, potential targets for new drug development
title_full_unstemmed From HIV to COVID-19, Molecular mechanisms of pathogens’ trade-off and persistence in the community, potential targets for new drug development
title_short From HIV to COVID-19, Molecular mechanisms of pathogens’ trade-off and persistence in the community, potential targets for new drug development
title_sort from hiv to covid-19, molecular mechanisms of pathogens’ trade-off and persistence in the community, potential targets for new drug development
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258762/
https://www.ncbi.nlm.nih.gov/pubmed/35818410
http://dx.doi.org/10.1186/s42269-022-00879-w
work_keys_str_mv AT abdelmassihantoine fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT sedkyabrar fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT shalabyahmed fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT shalabyalamirafawzia fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT yasseralia fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT mohyeldinaya fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT aminbasma fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT saleheenbasma fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT osmandina fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT samuelelaria fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT abdelfatahemmy fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT albustamieveen fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT elghamryfarida fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT khaledhabiba fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT amrhana fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT gaberhanya fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT makhloufismail fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT abdeldayemjanna fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT elbeialyjanawaleed fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT miladkarim fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT elsharkawilaila fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT abosennalina fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT safimadonnag fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT abdelkareemmariam fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT gabermarwa fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT elkadymirna fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT ihabmohamed fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT abdelraoufnora fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT khaledrawan fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT shalatareem fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT mahgoubrudayna fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT jamalsarah fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT elhawaryseifeldin fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT elrashidyshady fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT elshorbagysherouk fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT gergestony fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT kassemyara fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT magdyyasmeen fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT omaryasmin fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT shokryyasmine fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT kamelaya fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT hozaienrafeef fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT elhusseinynadine fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment
AT elshershabymeryam fromhivtocovid19molecularmechanismsofpathogenstradeoffandpersistenceinthecommunitypotentialtargetsfornewdrugdevelopment